ENGINEERING DILIGENCE FOR FRONTIER INVESTMENTS

Technical clarity for high-stakes bets in AI, life science and medical devices, deep tech, quantum, space, energy, aerospace, defense & robotics

START TODAY

Independent engineering diligence that uncovers real technical value — and the risks investors must know before they write the check.

Investing in frontier technology is a technical decision as much as a financial one. We provide engineering-led diligence that translates lab notebooks, prototypes, architectures, and supply chains into clear investment recommendations. Whether you’re evaluating a seed-stage AI stack, a quantum materials play, a molecular diagnostic system, or a space propulsion startup, we support investors with the technical evaluations and evidence they need: honest, verifiable, and actionable.

WHAT WE OFFER

CORE DILIGENCE SERVICES

  • Technical viability assessment - Validate core claims, reproducibility, and performance margins (on site and online options).

  • IP review - Technical review of patents, trade secrets, and potential infringement vectors.

  • Architecture and scalability review - Evaluate system design for production, cost, and scaling risks (software + hardware).

  • Prototype and lab validation - Reproduce key results, test prototypes, and interpret experimental data.

  • Supply chain and manufacturability analysis - BOM and supplier resilience, yield risk, and path to manufacturable product.

  • Cybersecurity and safety review - Threat modelling, attack surface analysis, and safety engineering (esp. for robotics, aerospace, defense).

  • Regulatory and standards readiness - Map required certifications, compliance gaps, and regulatory timelines.

  • Quantitative risk scoring - Standardized scoring across technical domains to support investment memos and portfolio comparisons.

COMMON DELIVERABLES

  • Executive one-page verdict & investment thesis alignment

  • Detailed technical report with evidence, test logs, and risk matrix

  • Reproducible test scripts, lab data, and annotated source excerpts (where permitted)

  • Workshop with founders and investors to align on de-risking plan

INDUSTRIES WE SERVE

We specialize in high-complexity sectors where technical nuance and subject matter expertise drives value:

  • Artificial intelligence & machine learning (model integrity, data provenance, inference infrastructure)

  • Life science and medical devices

  • Deep tech (novel materials, photonics, semiconductors)

  • Quantum (hardware architecture, coherence claims, error mitigation)

  • Space (propulsion, avionics, satellite systems, launch logistics)

  • Energy and clean tech (chemistry, grid integration, storage and conversion)

  • Aerospace and defense (systems engineering, reliability, mission assurance)

  • Robotics (perception, control stacks, real-world robustness)

OUR APPROACH

RIGOROUS, EVIDENCE-FIRST, INVESTOR-FACING

  1. Scope with clarity - We align on the investment question (e.g., “Is the core IP defensible?” or “Can this scale ?”) and define success metrics.

  2. Gather and verify evidence - During this phase, we source code, design docs, datasets, lab results, supplier contracts — we validate provenance and reproduce essential claims where possible.

  3. Test in relevant environments - Benchmarks, hardware-in-the-loop, simulation, MLOps reproducibility checks, and adversarial probes tailored to the technology.

  4. Quantify uncertainty - We convert qualitative concerns into quantitative risk scores and scenario impacts on commercial outcomes.

  5. Deliver investor-grade outputs - The P3PD team provides concise verdicts, detailed supporting evidence, and an actionable remediation roadmap with cost and time estimates.

WHY INVESTORS CHOOSE US

  1. Engineering-first team - The P3PD team consists of senior engineers, former R&D leads, and ex-manufacturing/QA directors with hands-on experience in the sectors we review.

  2. Independence & discretion - We operate under strict NDAs and present independent findings.

  3. Decision-centric reporting - Reports are structured to answer investor questions first: what to believe, what to worry about, and what to fix.

  4. Fast, configurable engagements - From rapid memos for screening to deep multi-month forensic reviews the P3PD team works fast.

COMPLETED WORK RESULTS

  • Seed AI startup - Identified data leakage in training pipeline that would have inflated production accuracy by 8–12%; recommended instrumentation and repeat evaluation before seed close.

  • Quantum hardware series A - Detected inconsistent measurement calibration that reduced claimed qubit fidelity; defined validation protocol and vendor checklist to reduce uncertainty by 60%.

  • Robotics pilot - Discovered brittle perception assumptions under real lighting; recommended a hardware/software redesign and edge compute budget that shortened time-to-product by 9 months.

PRICING AND ENGAGEMENT MODELS

We offer flexible pricing depending on scope:

  • Quick tech memo (2–5 business days) - Screening fee + fixed report.

  • Standard diligence (2–4 weeks) - Site/lab access, test execution, and full report.

  • Deep forensic (4–12 weeks) - Labs, prototyping, supplier audits, and remediation planning.
    Custom retainers available for portfolio monitoring and recurring technical reviews.

FAQ

Q: How long does a typical diligence take?
 A: Engagement length depends on scope; a focused memo can complete in days, a full forensic review in weeks. We provide a proposed timeline with each scope.

Q: Do you sign NDAs?
A: Yes — we routinely sign investor NDAs and can operate under founder NDAs where needed.

Q: Can you work with non-disclosure datasets or proprietary code?
A: Yes. We follow secure handling protocols and can run analyses in escrowed environments if required.

STARTING WITH YOUR INSPIRATION

Phase Three Product Development (P3PD) has simplified the product development process in the life science and medical device industries.

START TODAY

Arthur’s Rock - Fort Collins